Clinical trial
Effect of Growth Hormone in Metabolic Syndrome
NCT00307411 · Chinese University of Hong Kong, Other · Unknown status
Key facts
| NCT number | NCT00307411 |
|---|---|
| Title | Effect of Growth Hormone in Metabolic Syndrome |
| Official title | Effects of Growth Hormone on Body Fat Distribution, Insulin Action and Cardiovascular Risk Factors in Middle-Aged Men With Metabolic Syndrome |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | Growth hormone |
| Enrollment | 32 |
| Start date | Aug 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Mar 28, 2006 |
| Last update posted | Apr 4, 2006 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: